Lumexa Imaging Holdings

LMRI · NASDAQ

$10.68−$0.04 (−0.37%)TodayMarket closed · Oct 20, 4:38 PM ET

Prev close $10.72

LMRI analyst rating

BuyConsensus of 10 analysts over the last 12 months. 100% rate it a buy.

Strong buy1
Buy9
Hold0
Underperform0
Sell0

12-month price target · 10 analysts

Average $17.92 (+67.8% upside)

Low: $13.13
Now: $10.68
High: $24.15

Upgrades and downgrades

The latest rating actions, newest first

LMRI analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Truist Securities	Oct 5, 2026	Initiates	Buy	$18.00	100%
Keybanc	Sep 25, 2026	Initiates	Overweight	$18.00	61%
Barclays	Aug 28, 2026	Maintains	Overweight	$9.00 → $13.00	59%
Barclays	May 20, 2026	Maintains	Overweight	$15.00 → $9.00	59%
Barclays	Apr 14, 2026	Maintains	Overweight	$23.00 → $15.00	59%
Raymond James	Feb 9, 2026	Upgrade	Outperform → Strong Buy	$23.00	65%
Raymond James	Jan 5, 2026	Initiates	Outperform	$23.00	65%
Barclays	Jan 5, 2026	Initiates	Overweight	$23.00	—
Wells Fargo	Jan 5, 2026	Initiates	Overweight	$22.00	—
William Blair	Jan 5, 2026	Initiates	Outperform	—	15%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.